Profitable Gifts: A history of the Merck Mectizan® donation program and its implications for international health

Perspectives in Biology and Medicine

Volumn 47, Issue 1, 2004, Pages 100-109

  Collins, Kimberly ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN; TIABENDAZOLE;

CLINICAL TRIAL; DECISION MAKING; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HISTORY; HUMAN; MORALITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; VETERINARY MEDICINE;

EID: 1642456550     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2004.0004     Document Type: Review

References (6)

1. Appadurai, A. 1986. Introduction: Commodities and the politics of value. In The social life of things. Cambridge: Cambridge Univ. Press.
2. Aziz, M. A., et al. 1982. Efficacy and tolerance of Ivermectin in human onchocerciasis. Lancet (July 24):171.
3. Galison, P. 1999. Trading zone: Coordinating action and belief. In The science studies reader, ed. M. Bagioli, 137-60. New York: Routledge.
4. Nyiama, T. 1998. Community perspective on Mectizan's role as a catalyst for the formation of novel partnerships. Ann Trop Med Parasitol 92:S169-S170.
5. Useem, M. 1998. The leadership moment. New York: New Rivers Press.
6. Wehrwein, P. 1999. Pharmacophilanthropy. Harv Public Health Rev 35-36.